Pacific Biosciences (DE:P09)
BERLIN:P09
Holding DE:P09?
Track your performance easily

Pacific Biosciences (P09) Income Statement

2 Followers

Pacific Biosciences Income Statement

Last quarter (Q3 2024), Pacific Biosciences's total revenue was $39.97M, a decrease of -28.23% from the same quarter last year. In Q3, Pacific Biosciences's net income was $-60.73M. See Pacific Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 173.15M$ 200.52M$ 128.30M$ 130.51M$ 78.89M$ 90.89M
Cost of Revenue
$ 129.53M$ 147.74M$ 79.27M$ 71.65M$ 46.33M$ 56.31M
Gross Profit
$ 36.80M$ 52.78M$ 49.03M$ 58.86M$ 32.57M$ 34.58M
Operating Expense
$ 445.63M$ 363.14M$ 353.85M$ 269.30M$ 136.95M$ 135.12M
Operating Income
$ -408.83M$ -334.47M$ -307.20M$ -210.44M$ -104.39M$ -100.55M
Net Non Operating Interest Income Expense
$ -7.15M$ -14.34M$ -14.69M$ -12.53M$ -267.00K$ -2.61M
Other Income Expense
$ -35.06M$ 6.55M$ 5.26M$ 53.36M$ -36.05M$ -19.02M
Pretax Income
$ -394.96M$ -318.16M$ -314.25M$ -274.87M$ 29.40M$ -84.13M
Tax Provision
$ -718.00K$ -11.42M-$ -93.65M--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -394.24M$ -306.74M$ -314.25M$ -181.22M$ -68.60M$ -84.13M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 273.62M$ 510.89M$ 433.12M$ 340.95M$ 183.28M$ 191.44M
Net Income From Continuing And Discontinued Operation
$ -394.24M$ -306.74M$ -314.25M$ -181.22M$ 29.40M$ -84.13M
Normalized Income
$ -199.11M-----
Interest Expense
------
EBIT
$ -303.14M$ -303.82M$ -299.56M$ -262.34M$ 29.67M$ -81.52M
EBITDA
$ -260.74M$ -277.28M$ -282.24M$ -250.76M$ 38.97M$ -70.33M
Currency in USD

Pacific Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis